A DOUBLE-BLIND STUDY OF DEZOCINE IN CANCER PAINSTAQUET M.1979; J. CLIN. PHARMACOL.; USA; DA. 1979; VOL. 19; NO 7; PP. 392-394; BIBL. 3 REF.Article

A DOUBLE-BLIND COMPARISON OF MEPTAZINOL WITH PENTAZOCINE AND PLACEBO IN CANCER PAIN.STAQUET M.1978; J. CLIN. PHARMACOL.; U.S.A.; DA. 1978; VOL. 18; NO 1; PP. 76-79; BIBL. 6 REF.Article

EFFECT OF PARENTERAL DEZOCINE AND PLACEBO IN CANCER PAINSTAQUET M.1980; CURR. MED. RES. OPINION; GBR; DA. 1980; VOL. 6; NO 9; PP. 634-637; BIBL. 9 REF.Article

A DECISION THEORY APPROACH TO PHASE II CLINICAL TRIALS.STAQUET M; SYLVESTER R.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 26; NO 4; PP. 262-266; BIBL. 8 REF.Article

COMPARATIVE STUDY OF THREE ROUTES OF ADMINISTRATION OF SISOMICIN.MEUNIER CARPENTIER F; STAQUET M; KLASTERSKY J et al.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 11-12; PP. 625-630; BIBL. 9 REF.Article

EFFECT OF A NITROGEN ANALOG OF TETRAHYDROCANNABINOL ON CANCER PAIN.STAQUET M; GANTT C; MACHIN D et al.1978; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1978; VOL. 23; NO 4; PP. 397-401; BIBL. 12 REF.Article

GUIDELINES FOR THE PREPARATION OF E.O.R.T.C. CANCER CLINICAL TRIAL PROTOCOLSSTAQUET M; SYLVESTER R; JASMIN C et al.1980; EUROP. J. CANCER; GBR; DA. 1980; VOL. 16; NO 6; PP. 871-875; BIBL. 43 REF.Article

ANTIBACTERIAL ACTIVITY AND PHARMACOKINETICS OF BACAMPICILLIN AND AMPICILLINROZENCWEIG M; STAQUET M; KLASTERSKY J et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 5 PART. 1; PP. 592-597; BIBL. 17 REF.Article

EORTC RANDOMIZED TRIAL FOR THE ADJUVANT THERAPY OF T1 BLADDER CARCINOMA.SCHULMAN CC; ROZENCWEIG M; STAQUET M et al.1976; EUROP. UROL.; SWITZ.; DA. 1976; VOL. 2; NO 6; PP. 271-273; BIBL. 13 REF.Article

STUDY OF CIS-DIAMMINE-DICHLORO-PLATINUM IN ADVANCED SOFT TISSUE SARCOMA. PROTOCOL 62781, MARCH 1978PINEDO HM; VENDRICK CPJ; STAQUET M et al.1978; EUROP. J. CANCER; GBR; DA. 1978; VOL. 14; NO 10; PP. 1149-1152; BIBL. 6 REF.Article

SYNERGISM BETWEEN AMIKACIN AND CEFAZOLIN AGAINST KLEBSIELLA: IN VITRO STUDIES AND EFFET ON THE BACTERICIDAL ACTIVITY OF SERUM.KLASTERSKY J; MEUNIER CARPENTIER F; PREVOST JM et al.1976; J. INFECT. DIS.; U.S.A.; DA. 1976; VOL. 134; NO 3; PP. 271-276; BIBL. 10 REF.Article

Molécules d'adhésion : leur implication potentielle en dermatologie = Adhesion molecules: their potential involvement in dermatologySTAQUET, M. J; NICOLAS, J. F.Allergie et immunologie (Paris). 1990, Vol 22, Num 6, pp 211-215, issn 0397-9148, 5 p.Article

Similar epidermal changes in hyperkeratotic scabies of humans and pigsVAN NESTE, D. J. J; STAQUET, M. J.The American journal of dermatopathology. 1986, Vol 8, Num 3, pp 267-273, issn 0193-1091Article

Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cellsVERRIER, A. C; SCHMITT, D; STAQUET, M. J et al.International archives of allergy and immunology. 1999, Vol 120, Num 1, pp 56-62, issn 1018-2438Article

Clinical aspects of AIDS and AIDS-related complex, meeting, Brussels (Bruxelles), October 17-19 1985Baert, A; Hemmer, R; Staquet, M et al.Clinical aspects of AIDS and AIDS-related complex. Meeting. 1986, XX-209 p, isbn 0-19-261615-3Conference Proceedings

Etape indispensable à l'induction de l'hypersensibilité de contact = Langerhans cell migration. An essential step in the induction of contact hypersensitivitySTAQUET, M.-J; PICCARDI, N; MSIKA, P et al.Annales de dermatologie et de vénéréologie. 2002, Vol 129, Num 8-9, pp 1071-1077, issn 0151-9638, 7 p.Article

Human epidermal Langerhams cells express β1 integrins that mediate their adhesion to laminin and fibronectinSTAQUET, M.-J; LEVARLET, B; DEZUTTER-DAMBUYANT, C et al.Journal of investigative dermatology. 1992, Vol 99, Num 5, pp 12S-14S, issn 0022-202XConference Paper

Loratadine downregulates ICAM-1 expression on human keratinocytes and Langerhans cellsSTAQUET, M. J; REANO, A; SCHMITT, D et al.EJD. European journal of dermatology. 1996, Vol 6, Num 5, pp 369-372, issn 1167-1122Article

Human epidermal basal keratinocytes express CSw29 antigensSTAQUET, M. J; DEZUTTER-DAMBUYANT, C; ZAMBRUNO, G et al.British journal of dermatology (1951). 1989, Vol 121, Num 5, pp 577-585, issn 0007-0963Article

Fibronectin upregulates in vitro generation of dendritic langerhans cells from human cord blood CD34⁺ progenitorsSTAQUET, M. J; JACQUET, C; DEZUTTER-DAMBUYANT, C et al.Journal of investigative dermatology. 1997, Vol 109, Num 6, pp 738-743, issn 0022-202XArticle

The effect of trypsin on CD1 a molecule of human thymocytesDEZUTTER-DAMBUYANT, C; STAQUET, M. J; SCHMITT, D et al.Thymus. 1990, Vol 15, Num 4, pp 213-221, issn 0165-6090, 9 p.Article

Novel protein kinase C and matrix metalloproteinase inhibitors of vegetable origin as potential modulators of langerhans cell migration following hapten-induced sensitizationSTAQUET, M. J; PICCARDI, N; PICCIRILLI, A et al.International archives of allergy and immunology. 2004, Vol 133, Num 4, pp 348-356, issn 1018-2438, 9 p.Article

Occurrence of papillomavirus structural antigens in oral papillomas and leukoplakiasLÖNING, T; REICHART, P; STAQUET, M. J et al.Journal of oral pathology. 1984, Vol 13, Num 2, pp 155-165, issn 0300-9777Article

Reactivity pattern of a monoclonal antikeratin antibody (KL1)VIAC, J; REANO, A; BROCHIER, J et al.Journal of investigative dermatology. 1983, Vol 81, Num 4, pp 351-354, issn 0022-202XArticle

Use of human reconstructed epidermis to analyze the regulation of β-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPSCHADEBECH, P; GOIDIN, D; JACQUET, C et al.Cell biology and toxicology. 2003, Vol 19, Num 5, pp 313-324, issn 0742-2091, 12 p.Article